A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

A Phase II, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

(2019) Roy F Chemaly et al.   CLINICAL INFECTIOUS DISEASES

Accuracy and Discomfort of Different Types of Intranasal Specimen Collection Methods for Molecular Influenza Testing in Emergency Department Patients

(2018) Bradley W. Frazee et al.   ANNALS OF EMERGENCY MEDICINE

Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium

(2018) Daniel W Brookes et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Drug-Drug Interaction Profile of Presatovir

(2018) Yan Xin et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Phase 1 First-in-Human, Single- and Multiple-Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection

(2018) Polina German et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A Phase 2b Randomized Controlled Trial of Presatovir, an Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Lung Transplant (LT) Recipients

(2018) J. Gottlieb et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Supplemental Oxygen–Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus

(2017) Alpana Waghmare et al.   JOURNAL OF INFECTIOUS DISEASES

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

(2016) A. Waghmare et al.   BLOOD

Aerosolized ribavirin: the most expensive drug for pneumonia

(2016) R.F. Chemaly et al.   Transplant Infectious Disease

Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study

(2015) Richard L. Mackman et al.   JOURNAL OF MEDICINAL CHEMISTRY

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

(2015) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study

(2014) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

(2014)   PEDIATRICS

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections

(2013) D. P. Shah et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease

(2013) Yae-Jean Kim et al.   JOURNAL OF INFECTIOUS DISEASES

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

(2010) J. N. Shah et al.   BLOOD

Development and Evaluation of a Flocked Nasal Midturbinate Swab for Self-Collection in Respiratory Virus Infection Diagnostic Testing

(2010) M. Smieja et al.   JOURNAL OF CLINICAL MICROBIOLOGY